Evidence map›Paper›PMID 41908960›Full record

ArticleFrontiers in veterinary science2026

Integrated BLV surveillance in Kazakhstan, 2025: diagnostic complementarity and risk zoning.

Saltanat Mamanova, Markhabat Kassenov, Ainur Nurpeisova, Saira Kaimoldina, Elvira Bashenova, Aiken Karabassova, Vladimir Kirpichenko, Perizat Akshalova, Fariza Ikramkulova, Aigul Kassen and 11 more

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Saltanat MamanovaKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Markhabat KassenovKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Ainur NurpeisovaKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Saira KaimoldinaKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Elvira BashenovaKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Aiken KarabassovaKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Vladimir KirpichenkoKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Perizat AkshalovaKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Fariza IkramkulovaKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Aigul KassenKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Bakhyt TulepovKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Marat TurkeyevKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Zhandos AbayKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Maksat SerikovKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Zhibek ZhetpisbayDepartment of Computer Science, Kazakh National University, Almaty, Kazakhstan.
Malik YussupovKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.
Nurlan AkhmetsadykovResearch and Production Enterprise Antigen LLP, Almaty, Kazakhstan.
Tolganay ImanbekovaResearch and Production Enterprise Antigen LLP, Almaty, Kazakhstan.
Kunsulu ZakaryaNational Holding Qazbiopharm, JSC, Astana, Kazakhstan.
Nurkuisa RametovTecton Analytics LLP, Astana, Kazakhstan.
Raikhan NissanovaKazakh Scientific Research Veterinary Institute, LLP (KazSRVI), Almaty, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bovine leukemia virus (BLV) is a cell-associated retrovirus that remains endemic in many cattle-producing countries. In the absence of effective vaccination, BLV control relies on sustained surveillance and accurate interpretation of serological and molecular diagnostic data. However, the systematic integration of multiple diagnostic layers with spatial analysis at the national level remains limited in endemic settings. Methods: In 2025, a nationwide integrated surveillance of BLV was conducted in the Republic of Kazakhstan. A total of 3,650 serum samples were collected from 140 epidemiological units across 17 administrative regions. Cattle aged ≥24 months were examined using agar gel immunodiffusion (AGID) and enzyme-linked immunosorbent assay (ELISA) for serological screening, and polymerase chain reaction (PCR) for detection of proviral DNA. Partial sequencing was performed on selected PCR-positive samples for viral confirmation. Spatial analysis and territorial risk zoning were carried out using Geographic Information System (GIS)-based visualization to assess regional distribution patterns. Results: BLV infection exhibited pronounced spatial heterogeneity across the country. Serological screening identified regions with varying levels of BLV circulation, while PCR confirmed proviral presence in seropositive animals and in a limited number of seronegative cases. Discrepancies between AGID, ELISA, and PCR results reflected differences in diagnostic sensitivity and infection stage rather than methodological inconsistency. Integration of serological, molecular, and spatial data enabled classification of territories into distinct risk zones and identification of localized clusters of increased BLV circulation. Conclusion: Integrated surveillance combining serological testing, molecular detection, and spatial analysis provides a robust framework for assessing BLV epidemiology in endemic countries. The 2025 data from Kazakhstan demonstrate that diagnostic complementarity is essential for accurate spatial risk zoning and epidemiological interpretation. This framework supports risk-based decision-making and is readily transferable to other BLV-endemic settings with heterogeneous production systems, potentially informing the development of targeted surveillance and control strategies.

Indexed as

BLVbovine leukemia virusdiagnostic complementarityKazakhstanPCRseroprevalencespatial analysissurveillance

Identifiers

PMID41908960
PMCPMC13023132

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.